Access cutting-edge major depressive disorder treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access major depressive disorder specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related major depressive disorder treatment provided free
The goal of this clinical trial is to learn if GATE-251 works to treat depression in adults. It will also learn about the safety of GATE-251. The main questions it aims to answer are: Does GATE-251 reduce depression scores in participants compared to participants who take a placebo (a look-alike tablet that contains no GATE-251)? What medical problems are observed in participants who take GATE-251? Participants will take one tablet of GATE-251 or placebo every week for 6 weeks. Participants w
Sponsor: Syndeio Biosciences, Inc
Check if you qualify for this major depressive disorder clinical trial in Birmingham, AL
If you're searching for major depressive disorder treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced major depressive disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.